July 22, 2025 12:45 ET | Source: F. Hoffmann-La Roche Ltd Participation certificates (Partizipationsscheine) with a nominal value of CHF…
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage…
After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…